Get the Stockscreener App
11.67
0.77%
-0.09
Exagen Inc stock is traded at $11.67, with a volume of 101.92K.
It is down -0.77% in the last 24 hours and up +6.19% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$11.76
Open:
$11.76
24h Volume:
101.92K
Relative Volume:
0.44
Market Cap:
$256.78M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-12.41
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
-2.42%
1M Performance:
+6.19%
6M Performance:
+87.32%
1Y Performance:
+380.25%
1-Day Range:
$11.58
$11.82
1-Week Range:
$11.58
$12.23
52-Week Range:
$2.38
$12.23
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
11.67 | 258.76M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
567.39 | 210.04B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
215.38 | 151.90B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
629.51 | 50.29B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
146.36 | 40.64B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
216.46 | 36.86B | 15.90B | 1.28B | 2.21B | 7.2842 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | B. Riley Securities | Buy |
| Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-25 | Initiated | Craig Hallum | Buy |
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Exagen Inc. stock retracement – recovery analysisTrade Signal Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Exagen Inc. stock split attract more investorsBull Run & Free Expert Approved Momentum Trade Ideas - newser.com
Why Exagen Inc. (E08A) stock stays on buy listsQuarterly Earnings Summary & Short-Term High Return Strategies - newser.com
What valuation ratios show for Exagen Inc. (E08A) stockGap Down & Risk Adjusted Buy and Sell Alerts - newser.com
Is Exagen Inc. stock a top momentum playJuly 2025 Catalysts & Risk Controlled Stock Pick Alerts - newser.com
Why Exagen Inc. (E08A) stock could be next leader2025 Dividend Review & Free Real-Time Market Sentiment Alerts - newser.com
Is Exagen Inc. stock attractive for ETFsMarket Volume Summary & Low Risk Entry Point Guides - newser.com
Can trapped investors hope for a rebound in Exagen Inc.Rate Cut & Technical Pattern Recognition Alerts - newser.com
Will Exagen Inc. stock maintain momentum in 2025Weekly Investment Recap & Stock Timing and Entry Methods - newser.com
How higher bond yields impact Exagen Inc. (E08A) stockJuly 2025 Market Mood & Technical Pattern Recognition Alerts - newser.com
Will Exagen Inc. stock recover faster than peersGap Up & High Yield Stock Recommendations - newser.com
Will Exagen Inc. benefit from macro trendsJuly 2025 Summary & Expert Approved Momentum Trade Ideas - newser.com
Does Exagen Inc. stock trade at a discount to peersMarket Risk Summary & Reliable Intraday Trade Alerts - newser.com
How to monitor Exagen Inc. with trend dashboards2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - newser.com
Detecting support and resistance levels for Exagen Inc.Weekly Trade Recap & AI Based Buy/Sell Signal Reports - newser.com
Candlestick signals on Exagen Inc. stock todayJuly 2025 Momentum & Risk Managed Investment Entry Signals - newser.com
What to do if you’re stuck in Exagen Inc.2025 Risk Factors & AI Powered Market Entry Strategies - newser.com
Why Exagen Inc. stock is considered a top pick2025 Valuation Update & High Conviction Buy Zone Alerts - newser.com
Exagen Inc expected to post a loss of 16 cents a shareEarnings Preview - TradingView
Will Exagen Inc. stock deliver consistent dividends2025 Market Sentiment & Reliable Price Action Trade Plans - newser.com
Is Exagen Inc. stock poised for growthTrade Analysis Summary & Community Verified Swing Trade Signals - newser.com
Visual trend scoring systems applied to Exagen Inc.2025 Market Overview & Risk Managed Investment Entry Signals - newser.com
Is Exagen Inc. stock attractive for long term wealth buildingGDP Growth & Daily Entry Point Trade Alerts - newser.com
Strategies to average down on Exagen Inc.2025 Macro Impact & Reliable Volume Spike Trade Alerts - newser.com
Exagen Inc. (NASDAQ:XGN) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
How moving averages guide Exagen Inc. tradingJuly 2025 Action & Daily Growth Stock Investment Tips - newser.com
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):